Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $541.6M | $699.7M | $913.3M | $1,020.1M | $1,051.1M | $1,055.7M | $1,104.7M | $1,192.3M | $1,266.4M | $1,368.4M | $1,421.4M | $1,399.8M | $1,509.1M | $1,599.1M | $1,717.4M | $1,839.9M | $2,146.9M | $2,831.6M | $2,886.9M | $2,949.8M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, West Pharmaceutical Services, Inc.'s last 12-month Revenue is $2,876.3M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, West Pharmaceutical Services, Inc.'s Revenue growth was (1.7%). The average annual Revenue growth rates for West Pharmaceutical Services, Inc. have been 7.3% over the past three years, 9.9% over the past five years.
Over the last year, West Pharmaceutical Services, Inc.'s Revenue growth was (1.7%), which is lower than industry growth of 0.0%. It indicates that West Pharmaceutical Services, Inc.'s Revenue growth is Bad.